ArticleBrain & spine2025
Incidence of surgical site infections in cerebrovascular surgery: a single-center cohort study.
Article in Brain & spine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Incidence of surgical site infections in cerebrovascular surgery: systemic risk factors.Brain & spine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Surgical site infections (SSI) constitute a source of morbidity in neurosurgical patients. Few reports address incidence of SSIs in patients undergoing craniotomy for neurovascular diseases. Research question: This study aims to determine incidence and characteristics of SSI with interval to diagnosis, severity, and type of pathogen after intracranial neurovascular surgery. Materials and methods: Data from consecutive patients undergoing intracranial neurovascular surgery between January 2013 and 2022 were retrospectively analyzed in our tertiary referral center. Demographic data, risk factors, treatment and hospital stay were collected. Impact of SSI were classified according to Clavien Dindo Grade (CDG). Parameters studied included the time from index to revision surgery, microorganisms involved, and underlying pathology for the index surgery. Results: Among 1065 neurovascular surgeries, SSI occurred in 34 cases (2.1 %, n = 19 males). Median patient's age was 53 years (interquartile range, IQR 45-60). The median time from the index procedure to surgical wound revision was 27.5 days (IQR 19-44). The median length of hospital stay after revision surgery was 7 days (IQR 4-15). The predominant pathogen was Staphylococcus epidermidis (11, 32 %), followed by Staphylococcus aureus (8, 22 %). In 32 cases (89 %) wound revision was performed under general anesthesia. Discussion and conclusions: The overall incidence of SSI in our center was 2.1 % with a mean time to wound revision of 29 days. These numbers can be used as a benchmark and reference for strategies that implement a reduction of postoperative infections in neurovascular surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.